Fifth Third Bancorp
AMRX icon

Fifth Third Bancorp’s Amneal Pharmaceuticals AMRX Stock Holding History

Fifth Third Bancorp’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685K Sell
39,590
-561
-1% -$7.69K ﹤0.01% 1908
2026
Q1 		$499K Buy
+40,151
New +$539K ﹤0.01% 2044
2019
Q1 		– Sell
-512
Closed -$7K – 2146
2018
Q4 		$7K Buy
+512
New +$9.23K ﹤0.01% 1862

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Fifth Third Bancorp's AMRX Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Amneal Pharmaceuticals (AMRX) stake by 1.4% in Q2 2026, selling an estimated $7.69K and leaving 39,590 shares worth $685K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

Fifth Third Bancorp first reported a position in AMRX in Q4 2018 and has held it in 3 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Fifth Third Bancorp held 39,590 shares of Amneal Pharmaceuticals worth $685K as of Q2 2026.
  • Fifth Third Bancorp sold 561 Amneal Pharmaceuticals shares in Q2 2026, an estimated $7.69K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #1908 holding.
  • Fifth Third Bancorp first reported a position in Amneal Pharmaceuticals in Q4 2018 and has held it in 3 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.